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Treated with Gamma Knife Surgery, with More 
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all patients (100%) were pain free; the average time to com-
plete pain relief was 13.5 days (range: 0–240 days). Their ac-
tuarial probability of remaining pain free without medica-
tion at 0.5, 1 and 2 years was 93.1, 79.3 and 75.7%, respec-
tively, and remained stable until 13 years after treatment. 
The actuarial probability of hypoesthesia onset at 6 months 
was 4.3%; at 1 year it reached 13% and remained stable until 
13 years after treatment.  Conclusions: GKS proved to be rea-
sonably safe and effective on a long-term basis as a first- and/
or second-line surgical treatment for TN due to MBA com-
pression.  © 2014 S. Karger AG, Basel 
 Introduction 
 Trigeminal neuralgia (TN) – also known as ‘tic dou-
loureux’, as it was named by the French surgeon Nicholas 
André  [1] – is a serious health problem, with a prevalence 
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 Abstract 
 Background: Trigeminal neuralgia (TN) secondary to mega-
dolichobasilar artery (MBA) compression is considerably dif-
ficult to manage surgically.  Objective: This study aims to 
evaluate the safety/efficacy of Gamma Knife surgery (GKS) in 
this special group of patients.  Methods: Between July 1992 
and November 2010, 29 patients with >1 year of follow-up 
presenting with MBA compression were treated with GKS at 
Timone University Hospital. Radiosurgery was performed us-
ing a Gamma Knife (model B, C or Perfexion). A single 4-mm 
isocenter was positioned in the cisternal portion of the tri-
geminal nerve at a median distance of 9.1 mm (range: 6–18.2 
mm) from the emergence.  Results: The median follow-up 
period was 46.1 months (range: 12.9–157.9 months). Initially, 
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rate of 4–5 per 100,000 people  [2] . Several causes were 
identified as origins of TN, and vascular compression is 
considered to be one of the major pathogenic factors  [3–
5] . Usually, the vessels involved in the neurovascular con-
flict are arteries such as the superior cerebellar or anterior 
inferior cerebellar artery. Less frequently, prominent 
veins such as the petrosal veins or draining veins of the 
brainstem are also involved  [6] .
 Microvascular decompression (MVD) of the trigemi-
nal nerve is the most effective operation for treating pa-
tients with TN, with long-term cure rates between 69 and 
96% of the cases  [7–13] . Sindou et al.  [13, 14] proposed a 
surgical classification of the neurovascular compression 
and its severity, and demonstrated that this is a predictive 
factor for the results  [14] . This classification included the 
following grading: 1 – simple contact; 2 – distortion, and 
3 – marked indentation  [14] . In the case of compression 
of the trigeminal nerve by an ecstatic basilar artery, it is 
rather difficult to grade the conflict. Megadolichobasilar 
artery (MBA) compression is usually creating a marked 
indentation on the nerve and/or the adjacent brainstem, 
making it difficult to visualize in some patients.
 MBA compression has rarely been described in the lit-
erature; Jannetta  [15] did not refer to this condition in a 
series of 60 cases with TN due to vascular compression. 
Many case reports  [12, 16–29] , and recently a series  [30] , 
have described the topic of MBA-related TN, but only a few 
of them have included the results of decompressive vascu-
lar surgery  [12, 31] . There are several problems with MVD 
in MBA-related TN which render this type of intervention 
particularly difficult, such as a considerable risk of mobili-
zation of the trigeminal nerve because of the high internal 
turgor of these large vessels as well as a tendency for the 
patients to be older and to develop cranial nerve deficits 
more often than the MVD series as a whole  [12] . Beside 
MVD, other types of treatment have been reported in the 
literature, such as foramen magnum decompression  [17] .
 Gamma Knife surgery (GKS) is a minimally invasive 
surgical approach in the armamentarium for refractory 
TN  [32, 33] . Lars Leksell first introduced the concept of 
stereotactic radiosurgery in 1951, when he treated a pa-
tient suffering from essential TN using a prototype-
guiding device linked to a dental X-ray machine  [15, 34–
36] . Nowadays, the role of GKS in TN has been con-
firmed by several studies in terms of its safety and 
efficacy  [17, 37–42] , although until one year ago, none 
of them had specifically evaluated TN related to MBA 
compression. Recently, Park et al.  [30] reported on a 
first series of 20 patients and the results of GKS for TN 
due to vertebrobasilar ectasia.
 Our prospective study evaluates the safety and efficacy 
of GKS, using three parameters widely accepted in the 
literature: initial pain cessation, hypoesthesia and the 
probability of maintaining pain relief.
 Subjects and Methods 
 Patient Population and Selection 
 Between July 1992 and November 2010, 737 patients present-
ing with intractable TN were treated with GKS and followed up 
prospectively at Timone University Hospital in Marseille, France. 
Only patients fulfilling the criteria of the International Headache 
Society (2003)  [43] were accepted for treatment.
 An evaluation of the type of trigeminal pain was made accord-
ing to the classification proposed by Eller et al.  [44] into idiopath-
ic TN1 and TN2. While TN1 is typically described as sharp, shoot-
ing and electric-shock-like pain with pain-free intervals between 
the attacks, TN2 is described as aching, throbbing or burning pain 
for >50% of the time which is constant in nature (a constant back-
ground pain being the most significant attribute).
From our global series, thirty-three patients presented with TN 
related to MBA compression, of which 29 had >1 year of follow-up; 
their cases were further analyzed in this study. 
 Radiosurgical Technique 
 During the 18 years of the study, various models of the Gamma 
Knife were used (models B, C, 4C and Perfexion; Elekta Instru-
ment AB, Sweden). After application of the Leksell Model G ste-
reotactic frame (Elekta Instrument AB) under local anesthesia, all 
patients underwent stereotactic magnetic resonance imaging 
(MRI) and computed tomography (CT) scanning to identify the 
trigeminal nerve. The MRI sequences used were T2 type CISS 
without contrast (Siemens) and contrast-enhanced T1-weighted 
imaging. CT scanning routinely supplements the neuroradiologi-
cal investigation in order to correct any distortion errors on the 
MR images.
 In the Gamma Unit in Marseille, France, we use the anterior 
target, which means placing a unique 4-mm isocenter on the cis-
ternal portion of the trigeminal nerve using a very anterior target, 
located immediately posterior to the gasserian ganglion, as previ-
ously described  [33, 41] , at a median distance of approximately 7.5 
mm from the entry point of the trigeminal nerve into the brain-
stem, if the anatomical conditions allow. We initially give a dose 
of 90 Gy at the 100% isodose point. Beam channel blocking is used 
depending on the dose received by 10 mm 3 of the brainstem; 
should this dose be >15 Gy, we diminish the dose and then start 
plugging so as to be able to avoid increasing the length of the treat-
ed nerve, which could amount for more toxicity (the so-called 
Flickinger effect)  [34] .
 In the current series, a single 4-mm isocenter was used for all 
patients and was positioned in the anterior cisternal portion of 
the trigeminal nerve at a median distance of 9.1 mm (range: 
6–18.2 mm) anteriorly to the emergence of the nerve. Radiosur-
gical targeting can be very challenging in this special indication. 
Difficulties were sometimes encountered in visualizing the tri-
geminal nerve as the compression by the ecstatic MBA, depend-
ing on the grade of indentation in the nerve, made the targeting 
challenging.  Figure 1 presents the retrogasserian target, also 
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known as the Marseille target  [41] , adapted to this special ana-
tomical condition.
 Plugging was used in 8 patients (27.6%). The doses were rela-
tively high, with a median maximum dose of 90 Gy (range: 80–90 
Gy). No patient received <80 Gy at the 100% isodose point.
 Follow-Up and Assessment of Outcome 
 The Marseille Mediterranean University as well as the Direc-
tion and Ethics Committee of Timone University Hospital 
 (CPPRB1) approved our study. Follow-up information was ob-
tained in two ways: direct clinical evaluation or telephone inter-
view by the first author (C.T.), who was not involved in the selec-
tion of cases for treatment.
 We evaluated the probability of initial pain cessation, the onset 
of sensory disturbance and the rate of recurrence. We analyzed 
data regarding latency periods until becoming pain free, having a 
recurrence or developing a sensory disturbance, paying attention 
to date every event, the use of medication and the need for further 
surgical procedures so as to accurately assess all the available in-
formation.
 Pain was scored using 3 different scales: the Barrow Neuro-
logical Institute (BNI) pain scale (class I: ‘no trigeminal pain, no 
medication’; class II: ‘occasional pain, not requiring medication’; 
class IIIa: ‘no pain, continued medication’; class IIIb: ‘controlled 
with medication’; class IV: ‘some pain, not adequately controlled 
with medication’; class V: ‘severe pain, no pain relief’), the Burchiel 
scale (class I: ‘pain free, no medication’; class II: ‘pain free, on med-
ication’; class IIIa: ‘pain improved, no medication’; class IIIb: ‘pain 
improved, on medication’; class IV: ‘pain not improved’) and the 
Regis scale (class I: ‘no trigeminal pain, no medication’; class II: ‘no 
pain, with medication’; class III: ‘pain frequency reduction >90%’; 
class IV: ‘pain frequency reduction 50–90%’; class V: ‘no pain re-
duction’; class VI: ‘pain worsening’)  [45–47] . For hypoesthesia we 
used the BNI facial hypoesthesia scale (class I: ‘no facial numb-
ness’; class II: ‘mild facial numbness, not bothersome’; class III: 
‘facial numbness, somewhat bothersome’; class IV: ‘facial numb-
ness, very bothersome’)  [47] . For patients presenting facial sen-
sory dysfunction, we also inquired about their quality of life re-
lated to TN and whether this sensory problem was bothering them 
or not. We asked whether or not they had difficulties in mastica-
tion.
 The patients and referring doctor were instructed to continue 
and not change the medication for at least 1 month and then were 
asked to diminish the drug doses progressively if the patients were 
pain free. A case report form was created and filled out prospec-
tively since the first patient. The initial follow-up was based on a 
clinical evaluation – all patients being seen in person – for a prop-
er evaluation of the safety and efficacy of GKS, followed by a neu-
rological examination including facial sensibility and motility and 
corneal reflex at 3 months, 6 months and 1 year after the treat-
ment, and then regularly once a year. Every clinical evaluation 
made by our medical team during follow-up was prospectively 
noted in the database so as to have continuous up-to-date infor-
mation.
 Statistical Analysis 
 Data were recorded using Microsoft Excel 2000. All statistical 
analyses were performed using R version 2.12.0 (R Foundation for 
Statistical Computing, Vienna, Austria). The R survival package 
was used for survival analysis.
 First, a descriptive analysis of the recorded data was carried out 
among the MBA population. For the evaluation of outcomes such 
as initial pain cessation, hypoesthesia and recurrence, the time to 
the event was estimated by using the Kaplan-Meier method. A bi-
variate analysis was then performed to identify predictive factors 
among the collected variables. For qualitative variables, Kaplan-
Meier curves were used to graphically represent survival among 
the different groups, and they were compared using the univariate 
log rank test. For all variables, the effects were estimated and test-
ed by fitting univariate Cox proportional hazards regression mod-
els. Proportionality of hazards was assessed graphically by log cu-
mulative hazard plots.
 For qualitative variables, the χ 2 test was performed if valid, oth-
erwise Fisher’s exact test was used. For quantitative variables, the 
Mann-Whitney test was performed given the number of patients. 
All tests were two-sided, and p < 0.05 was judged to be significant.
 Fig. 1. Retrogasserian target (‘Marseille tar-
get’) in the special anatomical condition of 
ipsilateral trigeminal nerve compression by 
the MBA. 
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 Results 
 The preoperative clinical demographic data are shown 
in  table 1 . In this series, 13 patients (44.8%) were men and 
16 (55.2%) were women. The median age was 74.9 years 
(range: 51–90 years). The median follow-up period was 
46.1 months (range: 12–157 months). Trigeminal pain 
was more frequently encountered on the left side in 19 
patients (65.5%) compared with the right side in 10 pa-
tients (34.5%). Only 1 patient (3.4%) had bilateral pain. 
Pain was predominantly distributed in the V2 and V3 
dermatomes of the trigeminal nerve (41.4%), followed by 
only V2 (20.7%), only V3 (17.2%), V1 and V2 (13.8%), 
V1–V3 (3.4%), only V1 (3.4%), and V1 and V3 (0%).
 Two patients (6.9%) died from an unrelated cause but 
were not excluded from the study as they had had at least 
1 year of follow-up. Twelve patients (41.4%) were treated 
between July 1992 and December 2000 and 17 patients 
(58.6%) between January 2001 and March 2010. Six pa-
tients (20.7%) had undergone a prior surgical procedure, 
of which 2 (6.9%) had only had 1 previous intervention, 2 
(6.9%) had undergone 2 previous surgeries, and 2 patients 
(6.9%)  ≥ 3 previous surgeries. The previous surgical mo-
dality used was radiofrequency lesioning in 5 patients 
(17.2%), balloon microcompression in 3 patients (10.3%) 
and MVD in 1 patient (3.4%). Six patients (20.7%) had 
sensory disturbance preoperatively, which in all cases was 
a slight hypoesthesia with no severe hypoesthesia or anes-
thesia caused by earlier (nerve ablation) procedure(s) (for 
a general overview of the previous surgeries and previous 
side effects related to other interventions, see  table 2 ). GKS 
was the first surgical procedure in 23 patients (79.31%).
 The general postoperative outcome is shown in  ta-
ble 3 .  Table 4 shows the safety and efficacy of GKS over 
time, using the following parameters: initial pain cessa-
tion, hypoesthesia and the probability of recurrence.
Table 1. Preoperative clinical demographic data
Patients with MBA-related TN
Gender
Male
Female
29
13 (44.8)
16 (55.2)
Median age, years 74.9 (51 – 90)
Median duration of follow-up, months 46.1 (12.9 – 157)
Side of pain
Right
Left
Bilateral
10 (34.5)
19 (65.5)
1 (3.4) 
Pain distribution
V2 and V3
V2
V3
V1 and V2
V1–V3
V1
V1 and V3
12 (41.4)
6 (20.7)
5 (17.2)
4 (13.8)
1 (3.4)
1 (3.4)
0
Figures in parentheses are percentages or ranges.
 Table 2.  General overview of previous surgeries and side effects 
related to other interventions
Patients with MBA-related TN
No prior surgery
29
23 (79.3)
Prior surgery
1 surgery
2 surgeries
≥3 surgeries
6 (20.7)
2 (6.9)
2 (6.9)
2 (6.9)
Type of prior surgery
Radiofrequency lesion
Balloon microcompression
MVD
Glycerol rhizotomy
6 (20.7)
5 (17.2)
3 (10.3)
1 (3.4)
0
Side effects from prior surgery 6 (20.7)
Facial sensibility before GKS
Normal
Slight hypoesthesia
Severe hypoesthesia
Anesthesia
23 (79.3)
6 (20.7)
0
0
Figures in parentheses are percentages.
 Table 3.  Postoperative clinical GKS-related characteristics
Patients with MBA-related TN 29
Post-GKS sensory dysfunction
Mild
Severe
3 (13.04)
3 (100)
0
BNI facial hypoesthesia scale (related to GKS treatment)
No facial numbness
Mild facial numbness
Facial numbness, somewhat bothersome
Facial numbness, very bothersome
26 (89.7)
3 (10.3)
0
0
Additional treatment(s) after GKS
1 treatment
2 treatments
≥3 treatments
Balloon microcompression
Radiofrequency lesion
MVD
Cortical stimulation
Glycerol rhizotomy
3 (10.3)
3 (10.3)
0
0
2 (6.9)
1 (3.4)
0
0
0
Figures in parentheses are percentages.
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 Initial Pain Cessation 
 All 29 patients (100%) were initially pain free; the aver-
age time to complete pain relief was 13.5 days (range: 
0–240 days). The actuarial rate of initial pain cessation at 
0.5, 1, 2, 3, 4, 5 and 6 months was 62.1, 79.3, 93.1, 93.1, 
93.1, 96.5 and 96.5%, respectively. The pain distribution 
(in single vs. multiple territories) prior to GKS treatment 
was statistically significant for becoming pain free with
p = 0.01 (hazard ratio, HR = 0.37; confidence interval, CI, 
ranged between 0.17 and 0.8): 12 patients presented with 
trigeminal pain in 1 dermatome (log rank p = 0.03), 16 
patients in 2 dermatomes with a lower probability of be-
ing pain free (p = 0.02; HR = 0.37; CI ranged between 0.15 
and 0.89) and 1 patient in 3 dermatomes (p = 0.06; HR = 
0.12; CI ranged between 0.01 and 1.10). Neither age (p = 
0.15) nor the duration of symptoms prior to treatment
(p = 0.90) nor the presence of atypical pain (p = 0.94) nor 
previous surgeries (p = 0.73) nor sex (p = 0.16) showed 
any statistically significant correlation.  Figure 2 shows the 
actuarial probability of being initially pain free for the 
MBA population.
 Sensory Dysfunction after GKS 
 No patient had any early postoperative complications 
after GKS. Of the 23 patients with no preoperative hypo-
esthesia, 3 (13%) developed objective facial sensory loss, 
which occurred especially during the first 12 months after 
radiosurgery. Hypoesthesia onset was at a median of 7 
months (range: 5–12 months). The patients reported 
mild, not bothersome hypoesthesia in all 3 cases. The ac-
tuarial probability of hypoesthesia onset at 6 months was 
4.3%, and at 1 year 13%, remaining stable until 13 years. 
 We assessed hypoesthesia according to BNI facial hy-
poesthesia classes  [44] (see  table 3 ): class I in 20 patients 
(86.9%), class II in 3 patients (13.1%), class III in 0 pa-
tients and class IV in 0 patients. The 3 patients felt that 
their quality of life had improved after GKS and that the 
sensory dysfunction was a good trade-off for pain relief. 
Female patients statistically had a much lower probability 
of developing facial numbness, with a p value of 0.03 (in 
our series, no female patient with MBA-related TN had 
hypoesthesia after GKS). Hypoesthesia was predominant 
on the left side (66.7%; p = 0.912) and in the V2 derma-
tome (p = 0.288). No patient developed a trigeminal
motor deficit, or any other cranial nerve deficits, after 
GKS. No patient developed corneal sensory loss.  Figure 3 
shows the actuarial probability of hypoesthesia onset in 
the population with MBA-related TN.
 Maintaining Pain Relief after GKS and Management 
of Recurrence 
 Seven (24.13%) of the initially pain-free patients (n = 
29) experienced at least 1 recurrence after GKS. The me-
dian time to pain recurrence was 10.75 months (range: 
3.8–12.6 months).  Figure 4 shows the actuarial probabil-
ity of maintaining pain relief without medication for the 
29 patients with MBA-related TN. This probability at 0.5, 
1 and 2 years was 93.1, 79.3 and 75.7%, respectively, and 
remained stable until 12 years. Recurrence was especially 
related to preoperative pain within the V3 territory (p = 
0.023), atypical pain (p = 0.011; HR = 6.92; CI ranged be-
tween 1.54 and 31.12) and age (p = 0.005; HR = 0.89; CI 
ranged between 0.83 and 0.97). The following parameters 
were not statistically significant: postoperative hypoes-
thesia (p = 0.356; HR = 1), side of pain (p = 0.561), previ-
ous surgical treatments (p = 0.54), sex (p = 0.15) and du-
rability of the symptoms before GKS (p = 0.43).
 Table 4.  Main parameters evaluating outcome characteristics after 
GKS
Patien ts, n (%) Median period (range)
Pain free 29 (100) 13.5 (0 – 240) days
Hypoesthesia 3 (13.04) 7 (5 – 12) months
Recurrence 7 (24.1) 10.75 (3.8 – 12.6) months
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 Fig. 2. Actuarial probability of initial pain cessation free in the pop-
ulation with MBA-related TN. 
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 Because of recurrent medically refractory pain, 3 pa-
tients (10.34%) required further surgery ( table 3 shows 
the postoperative characteristics). In our unit, the most 
frequent intervention after failed GKS was balloon micro-
compression, practiced in 2 patients (6.9%), followed by 
thermocoagulation in 1 case (3.4%).
 Evaluation of Outcome at the Last Follow-Up 
 At the last follow-up, a good outcome was observed as 
follows: by the BNI scale in all 29 patients (100%), by the 
Burchiel classification in 24 patients (82.8%), and by the 
Regis classification in 28 patients (96.6%;  table 5 ).
 Discussion 
 The role of GKS in essential TN has evolved in the last 
20 years, and this kind of surgery nowadays represents a 
less invasive technique  [48, 49] for the treatment of in-
tractable TN, with results that vary from one study to an-
other in terms of initial pain cessation as well as hypoes-
thesia and recurrence rates  [37–39, 41, 42, 46, 50–55] .
 Regarding the etiology of TN, vascular compression is 
considered to be one of the major pathogenic factors  [3–
5] . Walter Dandy  [56] was the first to note the association 
between TN and vascular compression as well as their 
causal relationship. Since his observation, approximately 
34 studies of TN caused by vertebral and/or basilar artery 
compression have been published, usually in the form of 
case reports  [12, 16, 18–23, 25–29, 31, 57–59] . In most of 
them, the incidence of this anatomical condition ranges 
from 0 to 2.8%  [7, 13, 57, 60–62] , with only 1 large series 
from Japan reporting a higher incidence (7.7%)  [31] . Park 
et al.  [30] recently reported a percentage of 2% of the glob-
al population treated with GKS. In our study, the inci-
dence was 4.47%.
 MVD has been the accepted modality of treatment for 
TN caused by neurovascular compression  [63] . Thus, a 
few articles in the literature treated the subject of MVD in 
the case of MBA compression causing TN. Linskey et al. 
 [12] described a series of 31 patients of whom all were 
pain free (off medication) immediately after surgery and 
90% were pain free (off medication) at the time of the re-
port; 3 patients in that series had had pain recurrence. The 
overall 1-, 3- and 10-year rates of patients being pain free 
 Table 5.  Results at last follow-up by different evaluation scales
BNI Burchiel Regis
Good result, n (%) 29 (100) 24 (82.8) 28 (96.6)
Poor result, n (%) 0 5 (17.2) 1 (3.4)
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 Fig. 3. Actuarial probability of hypoesthesia onset in the popula-
tion with MBA-related TN. 
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 Fig. 4. Actuarial probability of maintaining pain relief in the popu-
lation with MBA-related TN. 
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(off medication) were 96, 92 and 86%, respectively. In 
terms of toxicity, 51.6% of the patients had minor trigem-
inal hypoesthesia/hypoalgesia preoperatively, and 41.9% 
of the patients had newly or mildly worsened minor hy-
poesthesia/hypoalgesia postoperatively, with only 1 pa-
tient having masseter weakness and major hypoesthesia 
(a patient who underwent a complete nerve section). Oth-
er deficits were trochlear or abducens nerve palsy (22.6%), 
hearing loss (12.9%) and aseptic meningitis (29%).
 Ogawa et al.  [58] reported the use of a synthetic vascu-
lar graft sutured to the clival dura to move the vessel away 
from the cranial nerves. Stone et al.  [59] used a silicone 
sling sutured to the petrous dura to reposition the basilar 
artery away from the trigeminal nerve. Takamiya et al. 
 [27] used a fenestrated clip and decompressed the nerves. 
Other authors, such as Goel and Shah  [17] , proposed fo-
ramen magnum decompression in a particular case of ec-
tatic basilar artery and basilar invagination. There was 
immediate relief from the neuralgic pain and no recur-
rence observed at 18 months.
 Park et al.  [30] recently published the first series in the 
literature concerning MBA-related TN treated with GKS. 
In their population, 75% of the patients achieved initial 
pain relief that was adequate or better (BNI pain scale 
classes I–IIIb), with a probability of maintaining pain re-
lief of 53, 38 and 10% at 1, 2 and 5 years, respectively. 
Some degree of facial sensory dysfunction occurred in 
10% of the patients. Fourteen patients (70%) underwent 
an additional surgical procedure.
 In our series, all the 29 patients (100%) had initial pain 
cessation without medication in a median time of 13.5 
days (range: 0–240 days). The hypoesthesia rate was low, 
with hypoesthesia present in only 3 patients (13.04%). Re-
current pain was observed in 7 patients (24.1%), of whom 
3 (10.3%) needed further surgery.
 Conclusions 
 GKS can be used as a first- and/or second-line treat-
ment for TN caused by MBA compression. The rarity of 
complications even in the long run and the considerable 
probability of a long-lasting effect make GKS a pragmat-
ic surgical first-intention treatment alternative for MBA-
related TN.
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